What is the sentiment of this news? Please choose an answer from {negative/neutral/positive}.

After the reporting period , BioTie North American licensing partner Somaxon Pharmaceuticals announced positive results with nalmefene in a pilot Phase 2 clinical trial for smoking cessation .
positive